Sorafenib inhibits transforming growth factor β1-Mediated Epithelial-Mesenchymal Transition and apoptosis in mouse hepatocytes
Epithelial-mesenchymal transition (EMT) is a physiological process that has been recognized to occur during the progression of an increasingly large number of human diseases, including liver fibrosis, cirrhosis, and hepatocellular carcinoma. The activation of transforming growth factor β (TGF-β) sig...
Saved in:
Main Authors: | Yue‐Lei Chen, Jing Lv, Xiaolei Ye, Mingyu Sun, Qin Xu, Chenghai Liu, Lihua Min, Huiping Li, Ping Liu, Xiaoyan Ding |
---|---|
格式: | Artigo |
语言: | 英语 |
出版: |
2011
|
在线阅读: | https://doi.org/10.1002/hep.24254 https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hep.24254 |
标签: |
添加标签
没有标签, 成为第一个标记此记录!
|
相似书籍
-
Sorafenib Inhibits Epithelial-Mesenchymal Transition through an Epigenetic-Based Mechanism in Human Lung Epithelial Cells
由: Zhang, Juyong, et al.
出版: (2013) -
Sorafenib Inhibits the Hepatocyte Growth Factor–Mediated Epithelial Mesenchymal Transition in Hepatocellular Carcinoma
由: Tomoyuki Nagai, et al.
出版: (2011) -
Sorafenib inhibits macrophage-mediated epithelial-mesenchymal transition in hepatocellular carcinoma
由: Yanru Deng, et al.
出版: (2016) -
Sorafenib inhibits macrophage-mediated epithelial-mesenchymal transition in hepatocellular carcinoma
由: Deng, Yan-Ru, et al.
出版: (2016) -
The hepatocyte-specifically expressed lnc-HSER alleviates hepatic fibrosis by inhibiting hepatocyte apoptosis and epithelial-mesenchymal transition
由: Zhang, Kun, et al.
出版: (2019)